Aktie INSD INSTADOSE PHARMA CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Instadose Pharma Corp.

Aktien

INSD

US45783B1035

INSD

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:34:47 29.12.2023 		% 5 Tage % 1. Jan.
0,000001 USD -.--% Intraday Chart für Instadose Pharma Corp. -.--% -.--%
2023 TetraPharma Royalty Corp. erwarb TetraPharma (Canada) Ltd. von Instadose Pharma Corp. (OTCPK:INSD). CI
2022 Instadose Pharma Corp. kündigt Änderungen im Vorstand an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..
An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Instadose Pharma Corp. Announces Board Changes
Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer
Instadose Pharma Corp. Announces CEO Changes
INSTADOSE PHARMA CORP. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)
INSTADOSE PHARMA CORP. : Financial Statements and Exhibits (form 8-K)
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Instadose Pharma Corp. Reports Earnings Results for the Full Year Ended November 30, 2021
INSTADOSE PHARMA CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Instadose US Announces Management Transition
Instadose US Announces Management Transition
Instadose Pharma Corp. Announces Management Transition
INSTADOSE PHARMA CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. INSD Aktie
  4. Nachrichten Instadose Pharma Corp.
  5. Andere Sprachen